Wednesday, April 18, 2018 6:22:59 PM
https://marapharm.com/investors/
Date: April 5 2018
Issued and Outstanding Share Capital: 111,785,822
Reserved for Issuance: 12,696,900
Warrants: 3,443,900
Stock Options Outstanding: 9,250,000
Tradeable Warrants: 43,749,053
Fully Diluted Share Capital: 168,228,775
https://www.otcmarkets.com/stock/MRPHF/disclosure
All filings are posted on sedar:
https://www.sedar.com/FindCompanyDocuments.do
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM